Pseudomyxoma peritonei laboratory findings: Difference between revisions
Nima Nasiri (talk | contribs) |
Nima Nasiri (talk | contribs) |
||
| Line 6: | Line 6: | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
The laboratory findings associated with pseudomyxoma peritonei are increased levels of tumor markers such as:<ref name=" | The laboratory findings associated with pseudomyxoma peritonei are increased levels of tumor markers such as:<ref name="pmid17510772">{{cite journal |vauthors=Baratti D, Kusamura S, Martinetti A, Seregni E, Laterza B, Oliva DG, Deraco M |title=Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |journal=Ann. Surg. Oncol. |volume=14 |issue=8 |pages=2300–8 |date=August 2007 |pmid=17510772 |doi=10.1245/s10434-007-9393-9 |url=}}</ref><ref name="pmid15932563">{{cite journal |vauthors=Alexander-Sefre F, Chandrakumaran K, Banerjee S, Sexton R, Thomas JM, Moran B |title=Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence |journal=Colorectal Dis |volume=7 |issue=4 |pages=382–6 |date=July 2005 |pmid=15932563 |doi=10.1111/j.1463-1318.2005.00773.x |url=}}</ref> | ||
*Carcinoembryonic antigen ([[CEA]]) | *Carcinoembryonic antigen ([[CEA]]) | ||
*Carbohydrate antigen 19.9 (CA19.9) | *Carbohydrate antigen 19.9 (CA19.9) | ||
Revision as of 20:46, 11 January 2019
|
Pseudomyxoma peritonei Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pseudomyxoma peritonei laboratory findings On the Web |
|
American Roentgen Ray Society Images of Pseudomyxoma peritonei laboratory findings |
|
Risk calculators and risk factors for Pseudomyxoma peritonei laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
The laboratory findings associated with pseudomyxoma peritonei are increased levels of tumor markers such as carcinoembryonic antigen (CEA), carbohydrate antigen 19.9 (CA19.9), carbohydrate antigen 125 (CA125).[1]
Laboratory Findings
The laboratory findings associated with pseudomyxoma peritonei are increased levels of tumor markers such as:[2][3]
These tumor markers are also used as a baseline value for postoperative follow-up. Moreover, they have been reported as predictors of the completeness of cytoreductive surgery, a significant prognostic factor for pseudomyxoma peritonei.[2]
References
- ↑ Amini, Afshin; Masoumi-Moghaddam, Samar; Ehteda, Anahid; Morris, David (2014). "Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects". Orphanet Journal of Rare Diseases. 9 (1): 71. doi:10.1186/1750-1172-9-71. ISSN 1750-1172.
- ↑ 2.0 2.1 Baratti D, Kusamura S, Martinetti A, Seregni E, Laterza B, Oliva DG, Deraco M (August 2007). "Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy". Ann. Surg. Oncol. 14 (8): 2300–8. doi:10.1245/s10434-007-9393-9. PMID 17510772.
- ↑ Alexander-Sefre F, Chandrakumaran K, Banerjee S, Sexton R, Thomas JM, Moran B (July 2005). "Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence". Colorectal Dis. 7 (4): 382–6. doi:10.1111/j.1463-1318.2005.00773.x. PMID 15932563.